Two steps forward, one step back: 4th WHO classification of myeloid neoplasms (2008)

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 3, 2010, Pages 391-394

  Bhargava, Rahul ^a   Dalal, Bakul I ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BCR ABL PROTEIN; CD135 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; GYRASE INHIBITOR; JANUS KINASE 2; NITRIC OXIDE SYNTHASE; NUCLEOPHOSMIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN; PROTEIN CEBPA; RETINOIC ACID; STEM CELL FACTOR; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE MEGAKARYOCYTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ANALYTICAL PARAMETERS; APLASTIC ANEMIA; ATYPICAL CHRONIC MYELOID LEUKEMIA; BLASTIC NK CELL LYMPHOMA; BLOOD CELL COUNT; BLOOD EXAMINATION; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CHROMOSOME 1; CHROMOSOME 11Q; CHROMOSOME 21Q; CHROMOSOME 22P; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CHRONIC NEUTROPHILIC LEUKEMIA; CRYOPRESERVATION; CYTOCHEMISTRY; CYTOGENETICS; DOWN SYNDROME; DYSERYTHROPOIESIS; EDITORIAL; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GRANULOCYTIC SARCOMA; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LYMPHOMA; MAST CELL LEUKEMIA; MEGAKARYOBLAST; MOLECULAR GENETICS; MONOCYTE MACROPHAGE PRECURSOR CELL; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; MYOBLAST; NEUTROPENIA; ONCOGENE N RAS; PLASMACYTOID DENDRITIC CELL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA AND RINGED SIDEROBLASTS; REFRACTORY THROMBOCYTOPENIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDEROBLASTIC ANEMIA; SYSTEMIC MASTOCYTOSIS; T CELL LEUKEMIA; THROMBOCYTE COUNT; TRANSLOCATION LINE; WORLD HEALTH ORGANIZATION;

HUMANS; LEUKEMIA, MYELOID; WORLD HEALTH ORGANIZATION;

EID: 77955894416     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.68240     Document Type: Editorial

References (15)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French- American-British (FAB) co-operative group. Br J Haematol 1976;33:451-458
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199
3. Bartlett JG, Hayden FG. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:460-462
4. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100: 2292-2302
5. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009;114:937-951
6. Vardiman JW. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms. Chem Biol Interact 2010;184: 16-20.
7. Wandt H, Schakel U, Kroschinsky F, Prange-Krex G, Mohr B, Thiede C, et al. MLD according to the WHO classification in AML has no correlation with age and no independent prognostic relevance as analyzed in 1766 patients. Blood 2008;111:1855-1861
8. Weinberg OK, Seetharam M, Ren L, Seo K, Ma L, Merker JD, et al. Clinical characterization of acute myeloid leukemia with myelodysplasiarelated changes as defined by the 2008 WHO classification system. Blood 2009;113:1906-1908
9. Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia/lymphoma: Towards a well defined entity? Br J Haematol 2007;136:539-548
10. Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, et al. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 2009;145:624-636
11. Alhan C, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA. Do peripheral blasts count in myelodysplastic syndromes? Leuk Res 2009;33:209-211
12. Bennett JM, Orazi A. Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: Recommendations for a standardized approach. Haematologica 2009;94:264-268
13. Campbell PJ, Bareford D, Erber WN, Wilkins BS, Wright P, Buck G, et al. Reticulin accumulation in essential thrombocythemia: Prognostic significance and relationship to therapy. J Clin Oncol 2009;27:2991-2999
14. Kwon M, Osorio S, Muñoz C, Sánchez JM, Buno I, Díez-Martín JL. Essential thrombocythemia in patients with platelet counts below 600x10(9)/L: Applicability of the 2008 World Health Organization diagnostic criteria revision proposal. Am J Hematol 2009;84:452-454
15. Wardrop D, Steensma DP. Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category? Br J Haematol 2009;144:809-817